Together we will beat cancer

Donate

Cancer Research UK and Lilly collaborate to trial combinations of potential new cancer treatments

Cancer Research UK’s Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.

Read More

Nearly all men survive testicular cancer

Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease latest figures show.

Read More

Researchers exploit cancer’s faulty defence mechanism

Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.

Read More

‘Treatment alliance’ needed to save more children’s lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

Read More

Diabetes treatment doubles skin cancer drug’s effectiveness

Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.

Read More

Scientists find new drug target for hard-to-treat leukaemia

Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia.

Read More

Cancer Research Technology appoints new chairman to its board of directors

Cancer Research Technology – the commercial arm of Cancer Research UK – today announced the appointment of Peter Chambrй as its new chairman.

Read More

Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing

Senectus Therapeutics has signed a deal to screen a selection of AstraZenecaїs chemical compound library to identify those which trigger a key element of cancer cell ageing ї called senescence.

Read More

Powerful online cancer drug discovery database unveiled

A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from ‘bench to bedside’.

Read More

Cancer Research UK and immatics biotechnologies launch trial for brain cancer

Cancer Research UK and Cancer Research Technology with immatics biotechnologies have launched the first trial of a promising cancer vaccine.

Read More